Lexicon Pharmaceuticals, Inc. financial data

Symbol
LXRX on Nasdaq
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 357 % -62.4%
Quick Ratio 0.36 % -79.8%
Debt-to-equity 98.2 % +45.3%
Return On Equity -52.9 % +51.1%
Return On Assets -26.7 % +58.6%
Operating Margin -94.4 % +97.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 363M shares +0.53%
Common Stock, Shares, Outstanding 366M shares
Entity Public Float 297M USD +8.55%
Common Stock, Value, Issued 366K USD +0.83%
Weighted Average Number of Shares Outstanding, Basic 363M shares +0.53%
Weighted Average Number of Shares Outstanding, Diluted 363M shares +0.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 70.9M USD +1255%
Revenue from Contract with Customer, Excluding Assessed Tax 6.17M USD +180%
Research and Development Expense 76.5M USD +5.42%
Costs and Expenses 138M USD -36.3%
Operating Income (Loss) -66.9M USD +68.3%
Net Income (Loss) Attributable to Parent -68.6M USD +68.3%
Earnings Per Share, Basic 0 USD/shares +76%
Earnings Per Share, Diluted 0 USD/shares +76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.7M USD +43.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.33M USD -19.4%
Inventory, Net 158K USD -75.2%
Other Assets, Current 4.09M USD -39.1%
Assets, Current 123M USD -54.4%
Property, Plant and Equipment, Net 1.98M USD -7.21%
Operating Lease, Right-of-Use Asset 7.51M USD +49.8%
Goodwill 44.5M USD 0%
Other Assets, Noncurrent 368K USD -55.6%
Assets 206M USD -35.9%
Accounts Payable, Current 3.8M USD -73.3%
Employee-related Liabilities, Current 4.79M USD -57.1%
Accrued Liabilities, Current 13.6M USD -37.7%
Contract with Customer, Liability, Current 4.3M USD
Liabilities, Current 21.7M USD -39.7%
Long-term Debt and Lease Obligation 5.48M USD +447%
Operating Lease, Liability, Noncurrent 6.8M USD +45.3%
Other Liabilities, Noncurrent 7.54M USD +13%
Liabilities 85.8M USD -39.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 29K USD -91.7%
Retained Earnings (Accumulated Deficit) -2B USD -3.55%
Stockholders' Equity Attributable to Parent 120M USD -32.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 120M USD -32.7%
Liabilities and Equity 206M USD -35.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -43.8M USD +20.6%
Net Cash Provided by (Used in) Financing Activities -572K USD -100%
Net Cash Provided by (Used in) Investing Activities 40.6M USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 366M shares +0.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.77M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 78.7M USD +128%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.97M USD -8.87%
Deferred Tax Assets, Valuation Allowance 421M USD +7.88%
Deferred Tax Assets, Gross 422M USD +7.79%
Operating Lease, Liability 8.44M USD +41.1%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68.9M USD +68.1%
Lessee, Operating Lease, Liability, to be Paid 12.1M USD +34.8%
Property, Plant and Equipment, Gross 4.57M USD +11.6%
Operating Lease, Liability, Current 1.64M USD +26.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.65M USD +35.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 424K USD +22.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 Rate +10.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.63M USD +22%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.68M USD +94.6%
Deferred Tax Assets, Operating Loss Carryforwards 316M USD +9.63%
Preferred Stock, Shares Issued 2.3M shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.72M USD +95%
Additional Paid in Capital 2.13B USD +0.53%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 176K USD +22.2%
Share-based Payment Arrangement, Expense 11.1M USD -27%
Interest Expense 8.78M USD +345%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%